Home › Therapeutic areas › Hematology › Polycythemia Vera
Polycythemia Vera (5 companies)
Companies with an active program in Polycythemia Vera.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| IRON | Disc Medicine | GI/HepatologyHematology+2 Rare | 1 | Phase 3 | 9 |
| IONS | Ionis Pharmaceuticals | CardiovascularHematology+5 Rare | 1 | Approved | 29 |
| PRLD | Prelude Therapeutics | HematologyOncology Rare | 1 | Phase 1 | 3 |
| PTGX | Protagonist Therapeutics | DermatologyHematology+2 Rare | 2 | Approved | 14 |
| VNDA | Vanda Pharmaceuticals | CardiovascularDermatology+6 Rare | 1 | Approved | 27 |
No companies match.